Daniel Ontaneda

Daniel Ontaneda

UNVERIFIED PROFILE

Are you Daniel Ontaneda?   Register this Author

Register author
Daniel Ontaneda

Daniel Ontaneda

Publications by authors named "Daniel Ontaneda"

Are you Daniel Ontaneda?   Register this Author

59Publications

769Reads

39Profile Views

Clinical commentary on "Warts and all: Fingolimod and unusual HPV associated lesions".

Mult Scler 2019 Oct 14;25(11):1550-1552. Epub 2018 Nov 14.

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518813109DOI Listing
October 2019

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis.

Lancet Neurol 2019 Oct 30;18(10):973-980. Epub 2019 Jul 30.

Clinical Neurology, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(19)30151-6DOI Listing
October 2019

Vitamin D and MRI measures in progressive multiple sclerosis.

Mult Scler Relat Disord 2019 Aug 13;35:276-282. Epub 2019 Aug 13.

Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.08.014DOI Listing
August 2019

Diagnosis and Management of Progressive Multiple Sclerosis.

Biomedicines 2019 Jul 29;7(3). Epub 2019 Jul 29.

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/biomedicines7030056DOI Listing
July 2019

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis.

J Vis Exp 2019 Jul 19(149). Epub 2019 Jul 19.

Department of Neurosciences, Lerner Research Institute, Cleveland Clinic;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59511DOI Listing
July 2019

MS progression is predominantly driven by age-related mechanisms - NO.

Mult Scler 2019 06 12;25(7):904-906. Epub 2019 Feb 12.

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518819712DOI Listing
June 2019

Progressive Multiple Sclerosis.

Authors:
Daniel Ontaneda

Continuum (Minneap Minn) 2019 06;25(3):736-752

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CON.0000000000000727DOI Listing
June 2019

Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis.

Mult Scler J Exp Transl Clin 2019 Apr-Jun;5(2):2055217319856035. Epub 2019 Jun 14.

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217319856035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572894PMC
June 2019

MOG-related disorders: A new cause of imaging-negative myelitis?

Mult Scler 2019 Apr 1:1352458519840746. Epub 2019 Apr 1.

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458519840746DOI Listing
April 2019

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Neurology 2019 Mar 20;92(11):519-533. Epub 2019 Feb 20.

From the Division of Neurology (J.O.), St. Michael's Hospital, University of Toronto, Canada; Department of Neurology (J.O., P.A.C., B.D., D.S.R.), Johns Hopkins University, Baltimore, MD; Mellen Center for Multiple Sclerosis (D.O.), Cleveland Clinic, OH; Department of Neurology (C.A., D.P.), University of Southern California, Los Angeles; Department of Neurology (E.C.K.), Massachusetts General Hospital, Harvard Medical School, Boston; Translational Neuroradiology Unit (M.A., G.N., P.S., D.S.R.), National Institute of Neurological Disorders and Stroke, Bethesda, MD; Brain Imaging Centre (D.L.A., S.N.), Montreal Neurological Institute, McGill University, Canada; Departments of Neurology (R.B.) and Radiology (R.B.), Brigham and Women's Hospital, Harvard Medical School, Boston; Department of Biostatistics (C.C.), Johns Hopkins School of Public Health, Baltimore, MD; Department of Neurology (L.F.), University of Texas Health Science Center at Houston; Department of Neurology (S.G., Y.W.), Weill Cornell Medical College, Cornell University, Ithaca, NY; Department of Neurology (R.H.), University of California at San Francisco; Department of Neurology (M.I., A.T.), Mount Sinai Hospital, New York, NY; Division of Neurology, Department of Medicine (S.K., D.K.B.L.), Department of Radiology (S.K., D.K.B.L., A.R.), Department of Physics and Astronomy (S.K., A.R., A.T., Y.Y.), MS/MRI Research Group (S.K., D.K.B.L., A.T., Y.Y.), MRI Research Centre (S.K., D.K.B.L., A.R.), and Department of Pediatrics (A.R.), University of British Columbia, Vancouver, Canada; A. A. Martinos Center for Biomedical Imaging (C.M.), Department of Radiology, Massachusetts General Hospital, Boston; Centre for Functional and Metabolic Mapping (R.S.M.), Robarts Research Institute, Western University, London, CA; Department of Neurology (F.N.), University of Minnesota, Minneapolis; Advanced Imaging Research Center (W.R., D.S., I.T.), Oregon Health & Science University, Portland; Department of Biostatistics, Epidemiology, and Informatics (R.T.S.), University of Pennsylvania Perelman School of Medicine, Philadelphia; Division of Neuroradiology and Neurophysics (T.Y.), University College London Institute of Neurology, UK; Department of Radiology (Y.Z.) and Department of Clinical Neurosciences and Hotchkiss Brain Institute (Y.Z.), University of Calgary, Canada; and Department of Neurology (N.L.S.), Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511106PMC
March 2019

Multiple sclerosis risk factors contribute to onset heterogeneity.

Mult Scler Relat Disord 2019 Feb 4;28:11-16. Epub 2018 Dec 4.

Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.12.007DOI Listing
February 2019

Identifying a new subtype of multiple sclerosis.

Neurodegener Dis Manag 2018 12 14;8(6):367-369. Epub 2018 Sep 14.

Medicine Institute, Mellen Center for Treatment & Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/nmt-2018-0032DOI Listing
December 2018

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.

Lancet Neurol 2018 10 22;17(10):870-884. Epub 2018 Aug 22.

Medicine Institute, Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(18)30245-XDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197820PMC
October 2018

Treatment decisions in MS: Shifting the goal posts or changing how we see them?

Mult Scler 2018 10 20;24(12):1523-1525. Epub 2018 Sep 20.

Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518801479DOI Listing
October 2018

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers.

Neurol Clin Pract 2018 Aug;8(4):292-301

Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus (BV, KN, SS, JRC, TV, EA), University of Colorado, Denver; Mellen Center for Multiple Sclerosis Treatment and Research (DO, RAB, RJF, JAC), Cleveland Clinic, OH; Emory University (AB), Atlanta, GA; Department of Neurology (SC), Cleveland Clinic, OH; and Lou Ruvo Center for Brain Health (CMH), Cleveland Clinic, Las Vegas, NV.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000487DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105060PMC
August 2018

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.

N Engl J Med 2018 08;379(9):846-855

From the Mellen Center for Multiple Sclerosis, Neurological Institute (R.J.F., S. Natarajan, R.A.B., D.O.), the Imaging Institute (X.H., M.J.L., K.E.S., X.Z.), and the Department of Biomedical Engineering (P.J., K.N., B. Thoomukuntla), Cleveland Clinic, Cleveland, Ohio State University, Columbus (M.R.), and University of Cincinnati, Cincinnati (A.Z.) - all in Ohio; the Data Coordinating Center, Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), University of Iowa, Iowa City (C.S.C., J.B., D.E., E.K., M.K., J.D.L., J.Y.); the National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.C.); the Clinical Coordinating Center, NeuroNEXT, Massachusetts General Hospital, Neurological Clinical Research Institute, Harvard Partners (M.E.C., M.M., A.A., B. Thornell), the Department of Neurology, Massachusetts General Hospital, Harvard Medical School (E.C.K.), and Brigham and Women's Hospital (C.S.), Boston; patient advocate (T.G.) and Swedish Medical Center at Seattle (P.R.), Seattle; University of Rochester Medical Center, Rochester (A.G.), Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Mount Sinai Medical Center (S.K.), Weill Cornell Medical College (J.S.P.), Columbia University Medical Center (C.S.R.), and Montefiore Medical Center, Albert Einstein College of Medicine (S.S.), New York, State University of New York (SUNY) at Stony Brook, Stony Brook (P.K.C.), SUNY Upstate Medical University, Syracuse (B.J.), and SUNY at Buffalo, Buffalo (B.W.-G.) - all in New York; MediciNova, La Jolla (K.M.), University of California at Davis, Sacramento (M.A.), and University of California at Los Angeles, Los Angeles (B.S.G.) - all in California; Washington University School of Medicine, St. Louis (R.T.N.); Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ (J.P.D.); NeuroRx Research, Montreal (S. Narayanan); the School of Health Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN (X.Z.); University of Colorado Denver, Aurora (E.A.); University of Alabama at Birmingham, Birmingham (K.B.); Feinberg School of Medicine, Northwestern University, Chicago (B.A.C.); University of Miami Miller School of Medicine, Miami (S.D.); University of Utah, Salt Lake City (L.D.D.); University of Texas Southwestern Medical Center, Dallas (A.F.); University of Virginia at Charlottesville, Charlottesville (M.D.G.); Emory University, Atlanta (N.L.); University of Kansas Medical Center, Kansas City (S.G.L.); Vanderbilt University, Nashville (H.M.); University of Pittsburgh Medical Center, Pittsburgh (V.S.); and Oregon Health and Science University, Portland (V.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1803583DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172944PMC
August 2018

Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm.

Mult Scler 2018 05 18;24(6):750-757. Epub 2017 Aug 18.

Translational Neuroradiology Section, Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517726383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794670PMC
May 2018

Stem cell injection-induced glioneuronal lesion of the cauda equina.

Neurology 2018 03 23;90(13):613-615. Epub 2018 Feb 23.

From the Cleveland Clinic Foundation (B.S.L., G.A.Y., D.S.B., Z.A., D.O., J.M., E.C.B.); and Cleveland Clinic Lerner College of Medicine (R.L.A.), Case Western Reserve University, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005219DOI Listing
March 2018

Smokers with MS have greater decrements in quality of life and disability than non-smokers.

Mult Scler 2017 Nov 6;23(13):1772-1781. Epub 2017 Jan 6.

Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516685169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494015PMC
November 2017

The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.

Neurotherapeutics 2017 Oct;14(4):905-923

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Avenue, U-10, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-017-0561-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722766PMC
October 2017

T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.

Ann Neurol 2017 Oct 21;82(4):635-639. Epub 2017 Sep 21.

Department of Neuroscience, Lerner Research Institute, Cleveland Clinic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.25019DOI Listing
October 2017

Clinical outcome measures for progressive MS trials.

Mult Scler 2017 Oct;23(12):1627-1635

Department NEUROFARBA, Section Neurosciences, University of Florence, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517729465DOI Listing
October 2017

The challenges and opportunities of multiple sclerosis care in Latin America.

Mult Scler J Exp Transl Clin 2017 Jul-Sep;3(3):2055217317720845. Epub 2017 Sep 25.

Department of Neurology, Raúl Carrea Institute for Neurological Research, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217317720845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617094PMC
September 2017

Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - Commentary.

Authors:
Daniel Ontaneda

Mult Scler 2017 04 11;23(4):508-509. Epub 2016 Oct 11.

Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Neurological Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516674368DOI Listing
April 2017

Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.

Lancet 2017 04 24;389(10076):1357-1366. Epub 2016 Nov 24.

Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(
Web Search
http://dx.doi.org/10.1016/S0140-6736(16)31320-4DOI Listing
April 2017

Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies.

Degener Neurol Neuromuscul Dis 2017 1;7:31-45. Epub 2017 Feb 1.

Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA,

View Article

Download full-text PDF

Source
https://www.dovepress.com/treating-primary-progressive-multi
Publisher Site
http://dx.doi.org/10.2147/DNND.S100096DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053100PMC
February 2017

Imaging as an Outcome Measure in Multiple Sclerosis.

Neurotherapeutics 2017 01;14(1):24-34

Mellen Center for Multiple Sclerosis, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-016-0479-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233623PMC
January 2017

Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 12-month follow-up.

Mult Scler Relat Disord 2016 Nov 8;10:44-52. Epub 2016 Aug 8.

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH, 44195 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.08.002DOI Listing
November 2016

Propensity methods for multiple sclerosis: The devil is in the details.

Mult Scler 2016 09 13;22(10):1248-9. Epub 2016 Jul 13.

Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH, USA/Department of Medicine, Case Western Reserve University, Cleveland, OH, USA/Center for Health Care Research & Policy, MetroHealth Medical Center, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516660390DOI Listing
September 2016

Heterogeneous depression trajectories in multiple sclerosis patients.

Mult Scler Relat Disord 2016 Sep 5;9:163-9. Epub 2016 Aug 5.

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2016.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031243PMC
September 2016

Experience with fingolimod in clinical practice.

Int J Neurosci 2015 29;125(9):678-85. Epub 2014 Oct 29.

1Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2014.969839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414718PMC
May 2016

Camptocormia and Pisa syndrome as manifestations of acute myasthenia gravis exacerbation.

J Neurol Sci 2015 Dec 19;359(1-2):8-10. Epub 2015 Oct 19.

Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2015.10.020DOI Listing
December 2015

Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.

CNS Drugs 2015 Sep;29(9):759-71

Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, 9500 Euclid Avenue/U10, Cleveland, OH, 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-015-0277-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621807PMC
September 2015

Identifying the start of multiple sclerosis injury: a serial DTI study.

J Neuroimaging 2014 Nov-Dec;24(6):569-576. Epub 2014 Feb 23.

Mellen Center, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jon.12082DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221810PMC
August 2015

Progressive multiple sclerosis.

Curr Opin Neurol 2015 Jun;28(3):237-43

Mellen Center for Multiple Sclerosis, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000195DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425257PMC
June 2015

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.

Lancet Neurol 2015 Feb;14(2):208-23

Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Institute of Neurology, University College London, London, UK; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(14)70264-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361791PMC
February 2015

Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder?

Int J Neurosci 2014 Jul 31;124(7):509-11. Epub 2013 Oct 31.

Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00207454.2013.854208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007377PMC
July 2014

Sensitivity to volatile anesthetics in patients with dementia: a case-control analysis.

Can J Anaesth 2014 Jul 25;61(7):611-8. Epub 2014 Apr 25.

Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12630-014-0165-2DOI Listing
July 2014

Multiple sclerosis treatment: risk mitigation.

Continuum (Minneap Minn) 2013 Aug;19(4 Multiple Sclerosis):1092-9

Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.CON.0000433280.10523.f0DOI Listing
August 2013

The benefits and risks of alemtuzumab in multiple sclerosis.

Expert Rev Clin Immunol 2013 Mar;9(3):189-91

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/eci.13.1DOI Listing
March 2013

Early tolerability and safety of fingolimod in clinical practice.

J Neurol Sci 2012 Dec 3;323(1-2):167-72. Epub 2012 Oct 3.

Mellen Center, Department of Neurology, Cleveland Clinic, Cleveland, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2012.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970706PMC
December 2012

Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.

Ther Adv Drug Saf 2012 Dec;3(6):291-303

Neurology Service, Hospital Clínico Universitario San Carlos, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2042098612462599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110840PMC
December 2012

EDSS improvement: recovery of function or noise?

Mult Scler 2012 Nov;18(11):1520-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512441689DOI Listing
November 2012

Multiple sclerosis: new insights in pathogenesis and novel therapeutics.

Annu Rev Med 2012 1;63:389-404. Epub 2011 Sep 1.

The Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev-med-042910-135833DOI Listing
May 2012

Potential mechanisms of efficacy and adverse effects in the use of fingolimod (FTY720).

Expert Rev Clin Pharmacol 2011 Sep;4(5):567-70

The Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/ecp.11.46DOI Listing
September 2011

Metabolic syndrome in small fiber sensory neuropathy.

J Clin Neuromuscul Dis 2011 Jun;12(4):235-43

Neuromuscular Center, Neurological Institute, Cleveland Clinic, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00131402-201106000-000
Publisher Site
http://dx.doi.org/10.1097/CND.0b013e3182196e3cDOI Listing
June 2011

Intracranial atherosclerosis as a risk factor for ischemic stroke during open heart surgery.

J Stroke Cerebrovasc Dis 2010 Jul-Aug;19(4):257-60. Epub 2010 May 14.

Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.04.011DOI Listing
October 2010

Management of acute exacerbations in multiple sclerosis.

Ann Indian Acad Neurol 2009 Oct;12(4):264-72

Neurological Institute, Cleveland Clinic, Cleveland, Ohio, 44195 USA.

View Article

Download full-text PDF

Source
http://www.annalsofian.org/text.asp?2009/12/4/264/58283
Publisher Site
http://dx.doi.org/10.4103/0972-2327.58283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824954PMC
October 2009

Race/ethnic differences in AD survival in us Alzheimer's disease centers.

Authors:
Daniel Ontaneda

Neurology 2009 May;72(18):1619; author reply 1620

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/01.wnl.0000346326.51499.beDOI Listing
May 2009

Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome.

Clin Neurol Neurosurg 2007 Jan 19;109(1):102-5. Epub 2006 Apr 19.

Maxine Mesinger MS Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2006.03.009DOI Listing
January 2007